| BioCryst Schweiz GmbH - Orladeyo 150 mg, Hartkapseln | | 68464 | | 01 | | Orladeyo 150 mg | | Hartkapseln | | B06AC06 | | Berotralstat | | 07.06.2022 | | |
| | Composition | | berotralstatum 150 mg ut berotralstati dihydrochloridum, amylum pregelificatum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: gelatina, E 171, E 132, E 172 (nigrum), E 172 (rubrum), Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), pro capsula. | | Packungsbestandteile | | Capsules | | | | | Active Agent | Dose |
|---|
| Berotralstatum | 150 mg |
| | BAG: Active Agent | Dose |
|---|
| Berotralstatum | 150 mg |
| | | | Inactive agents | | additional_information |
|---|
| (Nigrum) | | | | (Rubrum) | | | | Amylum Pregelificatum | | | | Crospovidonum | | | | E 132 | | color. | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Magnesii Stearas | | | | Pro Capsula | | | | Propylenglycol | | | | Silica Colloidalis Anhydrica | | |
| |
| |
|
